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Abstract
The dynamic kinetic resolution of α-keto esters via asymmetric transfer hydrogenation has been
developed as a technique for the highly stereoselective construction of structurally diverse β-
substituted-α-hydroxy carboxylic acid derivatives. Through the development of a privileged m-
terphenylsulfonamide for (arene)RuCl(monosulfonamide) complexes with a high affinity for
selective α-keto ester reduction, excellent levels of chemo-, diastereo-, and enantiocontrol can be
realized in the reduction of β-aryl- and β-chloro-α-keto esters.
1. INTRODUCTION
The enantioselective construction of α-hydroxy carboxylic acids remains an active area of
research due to their prevalence in biologically active molecules1 and use in asymmetric
synthesis.2 Reliable methods to prepare these compounds include enantioselective glycolate
aldol and alkylation reactions,3,4 reduction or alkylation of α-keto esters,5 Passerini-type
reactions,6 asymmetric cyanohydrin synthesis,7 and ester enolate oxygenations.8 Despite
advances in these methodologies, the preparation of β-stereogenic glycolic acid derivatives
remains much more challenging highlighting the importance of a generalizable strategy to
access these substructures.
The reduction of α-keto esters to give β-stereogenic-α-hydroxy esters has largely been
limited to the diastereoselective reduction of enantioenriched substrates.9 A more direct,
efficient reaction manifold might arise from the asymmetric catalyst-controlled reduction of
configurationally labile racemic β-substituted-α-keto esters. Such a reaction could in
principle proceed with concomitant formation of two (or more) stereogenic centers in a
single step and provide access to a number of functionalized glycolic acid derivatives
(Scheme 1).10 This strategy pre-supposes the application of a dynamic kinetic resolution
(DKR), a powerful tool for the conversion of racemic materials into enantiomerically
enriched products.11 In light of the prominence and utility of DKR reactions of α-
stereogenic-β-keto esters, the absence of complementary isomeric variants from racemic α-
keto esters was surprising. As part of our laboratory’s continued interest in glycolic acid
synthesis,12 we have recently developed a highly stereoselective dynamic kinetic resolution
of β-stereogenic-α-keto esters via asymmetric transfer hydrogenation (DKR-ATH), yielding
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trisubstituted γ-butyrolactones (vide infra).13 It occurred to us that substantial product
diversity might arise from a common mechanistic platform simply by varying the identities
of the nonhydrogen substituents (X and Y) at the β-carbon. The successful creation of an
attractive synthetic protocol would require: (1) simple routes to the needed racemic α-keto
ester substrates; (2) reaction conditions that achieve rapid substrate racemization; (3) the
identification of a reduction catalyst that is enantiomer-selective, provides strong facial bias
during the diastereoselective reduction, and can be applied to functionally diverse substrates.
The subject of this paper is the evaluation of this strategy and the presentation of a new
(arene)Ru catalyst system for the asymmetric dynamic reduction of a range of racemic β-
stereogenic-α-keto esters. The chemistry to be detailed was enabled by a seemingly trivial,
yet ultimately crucial deviation from established art in asymmetric Ru-catalyzed transfer
hydrogenation.
2. RESULTS AND DISCUSSION
2.1. Ligand/Catalyst Design
Inspired by the efficacy of Noyori’s (arene)RuCl(monosulfonamide-DPEN)14 in both the
asymmetric reduction of simple ketones15 and the dynamic reduction of α-substituted β-
keto esters and amides,16 we took this complex as our point of departure in ligand/ catalyst
design. Utilizing formic acid:triethylamine (5:2 mixture)17 as the organic reductant and 1a
as a test substrate, a screen of ligands and precatalysts was undertaken (Table 1). Initial
studies looked at the steric effects of the sulfonamide in Ru(II)-complexes possessing a (1S,
2S)-diphenylethylenediamine (DPEN) backbone. Subjecting 1a to 2 mol % of the ruthenium
dimer [RuCl2(arene)]2 and Noyori’s ligand L1 (Ru atom: L mole ratio 1:2) in DMF at 75
°C18 provided the desired γ-butyrolactone in high yield (90%) and diastereoselectivity
(>20:1 dr), but with low levels of enantiocontrol (57:43 er, entry 1). DPEN-based ligands
featuring bulkier sulfonamides (L2–L5) provided only modestly higher levels of selectivity
(entries 2–5). Employing L2, a screen of (arene)Ru(II)-precatalysts was conducted to
determine the role of the arene in the stereoselectivity of the reduction; however, no
improvements were observed moving away from [RuCl2(p-cymene)]2 (entries 6 and 7). In
addition to DPEN, 1,2-diaminocyclohexane and 1,2-aminoindanol were also investigated as
chiral backbones (L6 and L7), but yielded comparable results (entries 8 and 9).
Based on these preliminary findings that asymmetric transfer hydrogenation catalysts from
this family present in the literature were found to provide inadequate levels of selectivity, it
became clear that new chiral space would need to be explored in order achieve high levels of
enantiocontrol. Utilizing the “mother diamine”/diaza-Cope approach to the synthesis of C2-
symmetric 1,2-diamines,19 screening of a number of chiral diamine backbones was
conducted. The α-naphthyl/triisopropylbenzenesulfonamide ligand L8 considerably
increased the selectivity (88:12 er, Table 2). To further optimize the ligand structure,
perturbations of the sulfonamide were examined due to its apparent ability to directly impact
the chiral environment (Table 1, L1 vs. L2). Since less sterically encumbering sulfonamides
(L9–L12) resulted in erosions in selectivity, we sought to synthesize bulkier sulfonamides
by exploring new chiral space at the 2,6-positions of the arylsulfonamide.20 A number of
diverse sulfonyl chlorides were synthesized through a one-pot double alkylation/
sulfonylation of 1,3-dichlorobenzene.21 The simplest m-terphenyl sulfonamide variant L14,
distinguished itself as being uniquely effective for providing high levels of enantioselectivity
for the title reaction (95:5 er). The use of electron-withdrawing (L15) or releasing
substituents (L16) provided no improvement in selectivity. The α-naphthyl backbone and
m-terphenylsulfonamide operate synergistically; no improvement in enantiocontrol with the
DPEN/m-terphenylsulfonamide ligand L5 was observed (Table 1, entry 5). The α-naphthyl
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ethylenediamine backbone has been used sporadically in asymmetric synthesis and the use
of the m-terphenylsulfonamide for enantioselective catalysis is rarer still.22
2.2. Synthesis of Trisubstituted γ-Butyrolactones
This DKR-ATH was found to be applicable for a range of β-aryl α-keto esters.13 Electron-
rich, electron-poor, and heteroaryl substituents were tolerated at the β-position providing γ-
butyrolactone products in high yield and enantioselectivity. 23 Additionally, the reduction of
1g was performed on a 10 g scale employing reduced catalyst loading (1 mol % Ru) yielding
enantiopure lactone 2g in 72% yield following a single recrystallization. The absolute
stereochemistry of the trisubstituted γ-butyrolactone products was determined by X-ray
crystallographic analysis of 2b.24
The obtained functionally rich γ-butyrolactones can be deployed in secondary
transformations (Scheme 2). Diastereoselective alkylation of 2a employing allyl bromide
and DBU provided tetrasubstituted lactone 3a bearing an all-carbon quaternary carbon
center in high yield. Krapcho decarboxylation25 gave access to α-unsubstituted lactone 3b
(86% yield) that formally arises from cinnamic acid. When decarboxylation was preceded
by alkylation with dibromomethane, dehalodecarboxylation26 resulted and afforded α-
alkylidene γ-butyrolactone 3c. This substructure is prominent in natural product chemistry
and bioactivities within this subclass are well documented.27
2.3. “Free” Glycolate Michael Adducts Using Chemoselective DKR-ATH of α,δ-Diketo
Esters
2.3.1 DKR-ATH Approach to “Free” Glycolate Michael Adducts—Access to δ-
oxygenated glycolic acid derivatives via asymmetric glycolate Michael reactions is limited.
The most common approach to this class of compounds is the addition of stoichiometric
chiral glycolate enolates to α,β-unsaturated ketones and esters,28 and in each case the
protected glycolate is obtained (Scheme 3a). Only recently has a catalytic enantioselective
variant been disclosed; that method uses oxazolones as the α-hydroxy acid surrogate
(Scheme 3b).29 To the best of our knowledge, no catalytic enantioselective Michael addition
of a free glycolate enolate has been reported.30
Based on the success of the DKR-ATH of γ,γ-dicarboalkoxy-α-keto esters (1, vide supra),
we postulated that β-substituted-δ-keto-α-hydroxy esters might be accessible via a
chemoselective dynamic reduction of α,δ-diketo esters directly delivering the formal “free”
glycolate Michael adducts. Implicit in this analysis is the need for complete site selectivity
in the reduction. Methods for the selective reduction of an aldehyde in the presence of less
reactive carbonyls, i.e. ketones and esters, are well-established. 31 While significant progress
has been made in achieving the inverse process, the selective reduction of a ketone in the
presence of an aldehyde,32 the discrimination between two ketones remains a challenging
task. Examples of the latter include the chemoselective reduction of 2,4-diketo acid
derivatives using cinchona-modified platinum catalysts33 or baker’s yeast34 and aluminium-
mediated selective reductions of diaryl ketones.35 Our tactic takes advantage of the
heightened reactivity enjoyed by α-dicarbonyls and establishes a simple catalytic method for
achieving the formal asymmetric glycolate Michael construction without recourse to
auxiliary control or protection of the hydroxyl group (Scheme 3c).
2.3.2 Glyoxylate Stetter Addition with Enones—Indirect methods for the preparation
of the requisite α,δ-diketo esters 5 have been reported by us10b and others,36 but the most
direct and atom economical approach to these substrates would be a new Stetter reaction
between commercial ethyl glyoxylate and α,β-enones.37 This reaction was previously
reported to be unsuccessful with thiazolium carbenes,36c but we have found that effective
Steward et al. Page 3










catalysis can be realized by employing the Rovis triazolium carbene derived from salt 4.38
As outlined in Table 4, this glyoxylate Stetter addition is highly efficient, tolerant of a
number of ketonic substrates and substituents at the β-position and can be performed on a
multigram scale (entry 1). Notably, with the 1,4-dien-3-one dibenzyli-deneacetone,
exclusive monoaddition was observed (entry 5).
2.3.3 Chemoselective DKR-ATH of α,δ-Diketo Esters—Our investigation into the
chemoselective DKR-ATH began with an examination of the reduction of α,δ-diketo ester
5a. As shown in Table 5, our initial studies confirmed the feasibility of selectively reducing
the α-keto ester in the presence of an aryl ketone, as we observed exclusive formation of δ-
keto-α-hydroxy ester 6a as a single diastereomer. Subjecting 5a to our previously optimized
reaction conditions, 2 mol % of [RuCl2(p-cymene)]2 and diamine ligand L14 (Ru atom:L
mole ratio 1:2) in DMF at 70 °C using HCO2H/Et3N as the reductant, provided 6a in 96%
yield and a 91:9 er (entry 1). Lower levels of selectivity were observed when the reduction
was conducted at room temperature (87:13 er, entry 2). Further optimization revealed that
high levels of enantioselectivity (97:3 er) could be obtained by performing the reaction in
DMSO at room temperature (entry 6). The chemoselectivity observed is remarkable in light
of the extensive use of (arene)RuCl(sulfonamide) complexes for asymmetric transfer
hydrogenation of aryl ketones.14,15,17
With optimal reaction conditions in hand, we next explored other substrates in the
chemoselective dynamic reduction (Table 6). For all substrates examined, exclusive
reduction of the α-keto ester was observed, irrespective of the electronic characteristics of
the δ-ketone. High yields and enantioselectivities were obtained for substrates incorporating
electron-rich, electron-poor, and heteroaryl substituents at the β-position. The level of
selectivity for 6l (entry 12, 91:9 er) is noteworthy as this demonstrates that the scope is not
limited to β-aryl substrates (vide infra). 39 Additionally, other reducible functional groups
remained intact: the retention of the α,β-enone in 6e under the reaction conditions further
highlights the catalyst’s strong preference for the α-keto ester (entry 5). Aryl halides were
also tolerated (entries 2,7). To evaluate the catalytic efficiency of this system, the reduction
of 5a was performed using 0.05 mol % of [RuCl2(p-cymene)]2; no loss in reaction
efficiency was observed as 6a was obtained in 98:2 er (entry 1).
The absolute configuration and syn-stereochemical relationship of the α-hydroxy ester
products were determined by converting 6c to lactone 3b via a Baeyer-Villiger oxidation
followed by in situ lactonization; spectral data and optical rotation were in agreement with
those previously obtained by us for 3b.13
To determine if the [RuCl2(p-cymene)]2/L14 catalyst system was uniquely effective for the
reduction of α-keto esters, the chemoselectivity of transfer hydrogenation catalysts known
to reduce simple ketones was evaluated with 5a (Scheme 5). The use of ligand L2 in the
reduction, which is known to reduce acetophenone,40 also afforded 6a as the sole product,
albeit with lower levels of enantioselectivity (69:31 er). This result caused us to wonder if
the δ-ketone was possibly undergoing in situ “protection” as the lactol 7 following reduction
of the α-keto ester and that this intermediate masked the δ-ketone from further reduction. To
test this hypothesis, the reduction was monitored by 1H NMR spectroscopy in DMSO-d6,
but 7 was not detected: only the diketo ester 5a and hydroxy ester 6a were observed (Figure
1).
We then examined the transfer hydrogenation of several other ketone substrates using the
standard reaction conditions used in Table 6 (Scheme 6). Interestingly, acetophenone and
ethyl 2-ethyl-3-oxobutanoate, which are prototypical test substrates for new transfer
hydrogenation catalysts, are not reduced with this catalyst system. This lack of reactivity
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further highlights the unique preference for α-keto esters conferred by the newly developed
terphenylsulfonamide/di-α-napthylethylenediamine ligand. Reducing tert-butyl 2-oxo-4-
phenylbutanoate under the standard conditions proceeded efficiently, imparting good levels
of enantioselection and highlighting the potential applicability of this catalyst for simple α-
keto esters.
2.4. Chlorohydrin Synthesis
2.4.1 DKR-ATH Approach to Optically Active Chlorohydrins—The investigations
described above provide simple access to useful enantiomerically enriched glycolate
building blocks, but Scheme 1 implies a goal of diversification in product structures that had
not yet been realized. In considering new substrates that might be useful for DKR-ATH
reactions, the potential integration of β-halo substituents was appealing on several levels.
Optically active halohydrins are fundamental building blocks in organic chemistry and these
functional arrays can be converted to their derived enantioenriched epoxides or engage in
nucleophilic substitution to provide a variety of functionalized product classes (Scheme 7).
The emergence of halohydrin dehalogenase (HheC), an enzyme produced by Agrobacterium
radiobacter AD1, as a biocatalyst for the kinetic resolution of racemic haloalcohols
highlights the importance of methods for the preparation of optically pure terminal
halohydrins.41 The catalytic asymmetric preparation of halohydrins has been limited
principally to desymmetrization reactions of epoxides42 and alkenes43 or kinetic resolution
of terminal epoxides.42d,42g,42l,42m,44 Methodology designed to directly access internal
halohydrins from unsymmetrical precursors is largely underdeveloped (vide infra). We
sought to develop a stereoselective Ru-catalyzed dynamic kinetic resolution of β-chloro-α-
keto esters that would provide an efficient route to β-chloro-α-hydroxy esters.
Access to chiral β-chloro glycolic acid derivatives is currently limited to enzymatic
processes or stereospecific opening of glycidic esters with strong acids. While enzymatic
reductions45 and kinetic resolutions46 have been shown to impart good levels of diastereo-
and enantioselectivity, these processes are substrate limited and lack generality. Chloride
addition to optically pure glycidic esters often necessitates harsh reaction conditions, suffers
from non-ideal regio- and stereoselectivity, and lacks significant precedent for aliphatic
substrates.47 The dynamic kinetic resolution of α-chloro-β-keto esters has been developed
for some time,48 but the dynamic kinetic resolution of β-chloro-α-keto esters that would
provide isomeric products is heretofore unknown. Thus, we sought to develop a simple,
flexible synthesis of β-chloro glycolic acid derivatives employing a dynamic kinetic
resolution asymmetric transfer hydrogenation (DKR-ATH) of β-chloro-α-keto esters
(Figure 2).
2.4.2 Direct Catalytic β-Chlorination of α-Keto Esters—The relative dearth of
direct, catalytic β-functionalizations of α-keto esters presented an obstacle to the
implementation of this synthetic plan; in particular, methods for the direct β-halogenation of
α-keto esters are scarce.9k,45b,45c,49 Only two examples of the direct β-chlorination of singly
activated α-keto esters have been reported and those require either long reaction times or
harsh reaction conditions.45b,49a In order to synthesize the requisite β-chloro substrates for
the anticipated DKR-ATH, the development of a mild chlorination reaction of α-keto esters
was pursued. A screen of various Cu(II)-diamine and Ni(II)-diamine complexes led to the
identification of Sodeoka’s Ni(OAc)2-diamine complex 89i as an effective catalyst for the β-
chlorination of α-keto esters 9 using N-chlorosuccinimide (NCS) under mild reaction
conditions.50 As outlined in Table 7, the chlorination proceeds with good selectivity for the
singly halogenated product, is tolerant of a variety of functionalized aliphatic substrates, and
can be performed on a multigram scale (entry 1). The elevated acidity of β-aryl substrates
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favored dichlorination (entry 9); therefore, the requisite β-aryl substrates were prepared via
Darzens reaction.51
2.4.3 DKR-ATH of β-Chloro-α-Keto Esters—The reduction of β-chloro-α-keto esters
with NaBH4 proceeds with high levels of diastereoselectivity to afford the syn-diastereomer
via Felkin-Ahn control.46a Initial investigations into the DKR-ATH of 10a revealed that
ethylenediamine-derived 11a also afforded excellent levels of syn-selectivity (Figure 3);
however, the diastereochemical outcome was powerfully influenced by ligand selection.
Upon switching to Noyori’s parent Ru(II)-complex possessing a (1S,2S)-
diphenylethylenediamine (DPEN) backbone (11b),14 a significant erosion in syn-
diastereoselection was observed, albeit with promising levels of enantioselectivity. The
bulkier triisopropyl-DPEN ligand (11c) gave modest anti-diastereoselection with improved
enantiocontrol. Exploiting the unique properties associated with the terphenylsulfonamide
(vide supra), the DPEN-derivative 11d led to appreciable ligand-controlled
diastereoselection providing anti-12a with excellent levels of enantioselectivity. The α-
naphthyl backbone (11e) employed in the reduction of β-aryl-α-keto esters was found to
provide slightly higher levels of diastereoselection albeit with a small loss in
enantioselectivity. The diastereoselectivity and enantioselectivity were further improved in
DMF at 0 °C employing only 1 mol % of the Ru catalyst (in this case, the conveniently
prepared and stored dehydrohalgenated variant of 11d). Considering diastereoselectivity
only, the continuum expressed by Figure 3 (>20:1 syn:anti → 1:9 syn:anti at 298 K)
represents approximately 2.5 kcal/mol modulation of diastereomeric transition states
through simple substituent modifications on a common ligand framework.
With optimized reaction conditions in hand the relationship between α-keto ester structure
and reaction stereoselectivity was assayed (Table 8). A variety of aliphatic substrates were
found to be amenable to the reaction conditions providing β-chloro α-hydroxy esters with
excellent levels of diastereo- and enantioselection. Alkene, alkyne, and benzyloxy
functionality was tolerated under the reaction conditions offering value-added functional
handles. The method was also scalable (entry 1). The efficiency of these aliphatic substrates
under the DKR-ATH reaction conditions is a marked structural departure from the β-aryl
and β-ester requirements in antecedent work from our group and the paradigm that aryl
groups are necessary for high levels of enantiocontrol due to ligand/substrate π/C–H
interactions.52
Compatibility with β-aryl substrates was also demonstrated under the optimized reaction
conditions, providing adducts with excellent levels of enantioselectivity (Table 9). The
electronic character of the aromatic ring was found to significantly impact the
diastereoselectivity of the reaction. Electron-releasing groups engendered excellent
diastereocontrol (entries 2, 3, and 10) whereas electron-withdrawing groups provided
somewhat lower diastereoselection (entries 4, 7, and 8).
The absolute stereochemistry of the products was determined by comparison to the known
epoxide (2R,3S)-14,53 which was synthesized from chlor0hydrin (2S,3R)-13a upon
exposure to KOtBu (Scheme 7). To highlight the synthetic utility of the enantioenriched
chlorohydrins as synthetic building blocks, illustrative secondary transformations were
pursued. Treatment of chlorohydrin 13a with NaN3 afforded the azido alcohol 15
representing a formal synthesis of the paclitaxel C13 side-chain.47b Notably, the syn-product
15 is stereocomplementary to the anti diastereomer obtained from the glycidic esters that
one might derive from Darzens or Weitz-Scheffer reactions. Following triflate formation of
chloroalcohol 12a, chemoselective displacement with NaN3 affords α-azido-β-chloro ester
16 providing access to β-chloro-α-amino acid derivatives.
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The DKR-ATH is also amenable to the reduction of β-fluoro-α-keto esters. Preliminary
investigations have revealed that ketone 17 can be reduced under the optimized reaction
conditions to afford the derived fluorohydrin 18 in excellent yield as a mixture of
diastereomers (Scheme 8). Despite the lack of diastereocontrol in the reaction,54 excellent
levels of enantioinduction were observed for both diastereomers. This initial finding is quite
encouraging in light of the responsiveness of diastereocontrol to ligand structure in this
reaction family (vide supra).
3. CONCLUSIONS
In summary, we have designed new (arene)Ru(monosulfonamide) asymmetric transfer
hydrogenation catalysts that have led to the successful development of a highly modular
dynamic kinetic resolution of β-substituted-α-keto esters. The productive merger of a
common mechanistic framework and a new m-terphenylsulfonamide-based catalyst system
allow for rapid, atom-economical construction of highly functionalized glycolic acid
derivatives with excellent levels of chemo-, diastereo-, and enantioselectivity.
A formal asymmetric glycolate Michael reaction has been established via a catalytic
asymmetric chemoselective dynamic reduction of α,δ-diketo esters. The latter are prepared
via a new atom economical carbene-catalyzed Stetter reaction between commercial ethyl
glyoxylate and α,β-enones. The enantioselective reduction proceeds with high enantio- and
diastereoselectivity for a number of substrates. Initial investigations into the origin of the
observed selectivity suggests that the [RuCl2(p-cymene)]2/L14 catalyst system is uniquely
effective for the reduction of α-keto esters, as other ketone substrates (even acetophenone)
are unreactive under the standard reaction conditions.
Additionally, a highly stereoselective synthesis of β-chloro glycolic acid derivatives via
asymmetric transfer hydrogenation was developed. A Ni(II)-catalyzed chlorination of
aliphatic α-keto esters was developed to provide the requisite β-chloro-α-keto esters. In the
reduction of these ketones, careful catalyst tuning allows for a remarkable ligand-controlled
inversion of the preference for syn-selectivity to provide access to anti-chlorohydrins. The
DKR-ATH proceeds with high levels of diastereo- and enantioselectivity for a number of
aliphatic and aromatic substrates. The obtained chlorohydrins are versatile chemical building
blocks for valuable secondary transformations.
These studies collectively provide diverse glycolate-based building blocks for synthesis.
This study has highlighted some of the preparative and practical aspects of these reactions,
but open questions with respect to mechanism clearly remain (Scheme 9). Additional studies
to understand the catalyst-substrate interactions that account for the high levels of selectivity
observed are ongoing, with the goal of utilizing of this information in extensions to the
dynamic kinetic resolution of other useful frameworks.
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In situ monitoring of the reduction of (±)-5a by 1H NMR spectroscopy in DMSO-d6. Blue
panel: α,δ-diketo ester 5a; Red panel: in situ monitoring of reduction of α,δ-diketo ester 5a
to 6a (~50% conversion); Green panel: α-hydroxy-δ-keto ester 6a (with added HCO2H/
Et3N).
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Dynamic kinetic resolution of β-chloro-α-keto esters.
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Ligand-controlled switch in diastereoselectivity.a
aReactions were performed on 0.155 mmol scale employing 5 equiv. HCO2H:NEt3
(5:2). bDetermined by 1H NMR analysis of the crude reaction mixture. cDetermined by
chiral SFC analysis. dPerformed with 1 mol % catalyst in DMF (0. 1 M) at 0 °C for 10 h.
Complex 11da is the dehydrohalogenated variant of 11d; the structure is illustrated in Table
8.
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β-Stereogenic glycolic acid derivatives via reduction
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Reactions of lactone reduction product 2a
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Approaches to δ-oxygenated glycolic acid derivatives
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Stereochemical analysis of δ-keto-α-hydroxy esters
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Investigations into the observed chemoselectivity
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Other keto ester reductions
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Secondary transformations of chlorohydrin products.
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DKR-ATH of β-fluoro-α-keto ester 17.
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Table 1
Evaluation of chiral diamine ligands
entry L arene er
1 L1 p-cymene 57:43
2 L2 p-cymene 70:30
3 L3 p-cymene 62:38
4 L4 p-cymene 70:30
5 L5 p-cymene 72:28
6 L2 C6Me6 62:38
7 L2 benzene 71:29
8 L6 p-cymene 73:27
9 L7 p-cymene 60:40
a
Conditions: 1a (1.0 equiv), [RuCl2(arene)]2 (0.02 equiv), L (0.08 equiv), HCO2H:NEt3 (5.0 equiv), [1a]0 = 0.1 M in DMF, 75 °C, 16 h.
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Table 2
Evaluation of sulfonamides on α-naphthyl backbone
a
Conditions: As described for Table 1.
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Table 3
DKR-ATH substrate scopea
entry R2 2 yield (%)b erc
1 4-Cl-C6H4 2b 94 96:4
2 4-Me-C6H4 2c 84 95.5:4.5
3 4-MeO-C6H5 2d 90 95:5
4 4-CN-C6H5 2e 88 95:5
5 2-Me-C6H5 2f 82 89:11
6d piperonyl 2g 72 95:5
7 2-furyl 2h 91 95:5
8 N-Ts-indol-3-yl 2i 91 96.5:3.5
9 N-Boc-indol-3-yl 2j 88 96:4
a




Enantiomeric ratio determined by HPLC/SFC analysis.
d
[RuCl2(p-cymene)]2 (0.5 mol %), L14 (2 mol %), 10 g scale, >99.5:0.5 recrystallized.
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Table 4
Scope of the glyoxylate Stetter addition with enonesa
entry R1 R2 5 yield (%)b
1c C6H5 C6H5 5a 97
2 C6H5 4-I-C6H4 5b 95
3 C6H5 4-MeO-C6H5 5c 86
4 C6H5 Me 5d 72
5 C6H5 (E)–CH=CHPh 5e 91
6 C6H5 piperonyl 5f 92
7 4-Cl-C6H4 C6H5 5g 94
8 4-MeO-C6H4 C6H5 5h 96
9 2-Me-C6H4 C6H5 5i 70
10 3-Me-C6H4 C6H5 5j 93
11 4-Me-C6H4 C6H5 5k 95
12 CO2Et C6H5 5l 92
13 piperonyl C6H5 5m 94
14 N-Boc-Indol-3-yl C6H5 5n 74
a




Reaction performed on a 20 mmol scale.
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Table 5
Chemoselective DKR-ATH: reaction optimization a
entry solvent T (°C) yield (%)a erc
1 DMF 70 94 91:9
2 DMF rt 93 87:13
3 2-MeTHF 70 90 65:35
4 DCE 70 91 78:22
5 DMSO 70 96 97:3
6 DMSO rt 98 97:3
a




Enantiomeric ratio determined by SFC analysis.
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Table 7
Ni(II)-catalyzed β-chlorination of α-keto esters.a
entry R 10 mono:dib yield (%)c
1d –CH2Ph 10a 9:1 81
2 –CH2p-ClPh 10b 10:1 83
3 –CH2p-MeOPh 10c 12:1 84
4 –CH2CH2Ph 10d 8:1 78
5 –CH2CH=CH2 10e 13:1 86
6 –CH2C≡CTMS 10f 10:1 79
7 –(CH2)2CH3 10g 13:1 87
8 –(CH2)3OBn 10h 13:1 86
9 –Ph 10i 1:>20 trace
a
Unless otherwise noted, all reactions were performed on a 1.0 mmol scale.
b




Performed on 8.0 mmol scale.
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